Corvus Pharmaceuticals, Inc. (CRVS)
16.17
-1.67
(-9.36%)
USD |
NASDAQ |
Mar 05, 13:03
Corvus Pharmaceuticals Research and Development Expense (Annual) : 19.38M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Plus Therapeutics, Inc. | 10.58M |
| Geron Corp. | 71.43M |
| Jaguar Health, Inc. | 16.54M |
| Krystal Biotech, Inc. | 52.32M |